Regenxbio reported promising interim data from a phase 1 trial of its gene therapy for wet age-related macular degeneration (AMD). The treatment, designed to…
Agilent Technologies’ PD-L1 assay received an expanded label in Europe to help guide the use of first-line Keytruda in urothelial carcinoma. Physicians can now…
SQZ Biotechnologies has raised $72 million. The series C round sets the Roche-partnered MIT spinout to advance cell therapy treatments of solid tumors and…
Fruit fly larvae can taste ribonucleosides, the building blocks of gene transcripts, according to a new study publishing on August 7 in the open-access journal…
On August 11, people around the world will be treated to a partial solar eclipse. Solar eclipses occur the moon moves between the sun and Earth, blocking the…
Spark Therapeutics’ hemophilia A gene therapy reduced bleeding by 97% in a phase 1/2 trial, building on data reported in December that suggested it may not be…